This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cellectis. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Frederic Cedrone: Innovator in Genetic Disease Treatment
Introduction
Frederic Cedrone is a notable inventor based in Paris, France. He has made significant contributions to the field of genetic disease treatment through his innovative work. His research focuses on developing methods to address genetic disorders caused by specific mutations.
Latest Patents
Frederic Cedrone holds a patent for "Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations." This invention relates to a method for treating genetic diseases in individuals affected by frame shift or non-sense mutations in the human dystrophin gene. The method involves using meganuclease enzymes that recognize and cut target sites in the gene, thereby providing a potential therapeutic approach for these genetic conditions. The patent highlights the use of a kit that includes at least one meganuclease enzyme and a medicament containing the enzyme.
Career Highlights
Cedrone is associated with Cellectis, a company known for its pioneering work in gene editing and genetic therapies. His role at Cellectis has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Frederic Cedrone has worked alongside Jacques P Tremblay, enhancing the collaborative efforts in their research endeavors. Their combined expertise has furthered the understanding and development of innovative treatments for genetic diseases.
Conclusion
Frederic Cedrone's contributions to genetic disease treatment through his patented methods demonstrate his commitment to advancing medical science. His work at Cellectis and collaborations with other experts highlight the importance of innovation in addressing complex genetic disorders.